GenAI ROI in GCCs: Quick Wins Versus Long-Term Transformation

Generative AI has moved from pilot to production in India’s GCC ecosystem faster than almost anyone predicted. The question boards and CFOs are asking their GCC leaders in 2026 is no longer ‘Are you using GenAI?’ — it is ‘What is it actually worth to us?’

That question is harder to answer than it should be. According to the EY GCC Pulse Report 2025, 83% of GCCs are actively scaling GenAI projects and 58% are investing in Agentic AI. But the same research shows that most GCCs are measuring AI ROI through cost reduction proxies — headcount efficiency, processing speed, error reduction — rather than the business outcome metrics that actually matter to the enterprise. The result is a growing credibility gap: GCC leaders believe they are delivering value; their boards are not yet convinced.

The resolution to that gap lies in understanding that GenAI ROI operates at two speeds — and that pursuing only one of them is a strategic mistake.

Speed One: The Quick Wins That Pay for the Transformation

The fastest and most measurable GenAI returns in GCCs are in high-volume, rules-governed transactional functions. Automation research from Inductus GCC confirms that finance and accounting functions lead in GenAI ROI: accounts payable processing cycles reduced from 9.1 days to 1.4 days, cost-per-invoice dropping by over 60%, and error rates approaching near-zero in end-to-end automated pipelines. These are not pilot results — they are production outcomes in GCCs that implemented GenAI-assisted AP workflows in 2024 and have 18+ months of operational data.

Beyond finance operations, the pattern of quick wins follows a consistent logic: GenAI delivers fastest ROI where tasks are high-volume, text or data-rich, have clear quality standards, and currently involve significant human processing time. Document review, compliance monitoring, quality assurance testing, code review, and first-level customer support all fit this profile. The productivity uplift data is consistent across sources — randomised controlled trials in software delivery contexts report approximately a 26% increase in task completion rates when GenAI tools are introduced for less experienced developers, who show the highest adoption and productivity gains.

For a mid-market GCC of 100–300 people, three to five well-scoped quick-win deployments can generate enough productivity recapture — in the form of capacity freed for higher-value work — to fund the cost of the GenAI infrastructure investment within 12–18 months. This is the ROI narrative that builds board confidence and secures the budget for the longer-horizon transformation work. Enorbe’s Business Advisory team helps GCC clients identify, scope, and sequence these quick-win deployments as the foundation for a multi-year GenAI roadmap.

Speed Two: The Long-Term Transformation That Defines Enterprise Value

Quick wins produce cost efficiency. Long-term GenAI transformation produces competitive differentiation — and the distinction matters enormously for how a GCC is perceived and valued at the enterprise level. According to Accenture’s GCC India report, the 29% of GCCs that have achieved the deepest AI integration are 73% more likely to invest in GenAI, measure performance by innovation and IP creation at twice the rate of other GCCs, and show 84% emphasis on speed to market — a 42% advantage over peers. These are not operational efficiency metrics. They are business value metrics that show up in revenue, not in cost lines.

Long-term GenAI transformation in GCCs takes three to five years and involves a fundamentally different operating model: AI-native workflows where humans and AI systems collaborate on complex reasoning tasks rather than AI replacing humans on routine ones; proprietary AI capabilities developed and owned by the GCC rather than deployed off-the-shelf tools; and AI embedded in product development, financial modelling, and strategic analysis rather than confined to operational automation.

The critical distinction is that long-term transformation cannot be sequenced after the quick wins — it must be designed in parallel, from the beginning. GCCs that deploy GenAI only for operational efficiency and expect transformation to follow organically are consistently disappointed. The Hexaware GCC Trends 2026 report makes this explicit: GCCs should measure innovation ROI through product launches, improved customer experiences, R&D advancements, and business process optimisation — a broader view of value creation that requires a broader definition of the GenAI mandate from day one.

The ROI Measurement Framework That Boards Actually Want

The most common reason GenAI ROI conversations with boards stall is that GCC leaders present operational metrics — processing time, error rates, FTE equivalents saved — to audiences that think in revenue, margin, and competitive position. Translating GenAI ROI into board language requires a layered measurement framework:

• Efficiency ROI (0–12 months): Cost per transaction, processing cycle time, error rate, FTE capacity recaptured. These prove that GenAI investment is not wasted and fund the next phase.
• Capability ROI (12–36 months): Speed-to-delivery for new features or analyses, quality uplift in outputs (code quality, financial model accuracy, document precision), talent leverage ratio (output per professional). These show that GenAI is making your GCC more capable, not just cheaper.
• Strategic ROI (36+ months): New revenue streams enabled by GCC AI capability, competitive advantages created through proprietary AI tools, business decisions improved by AI-augmented analysis. These are the metrics that justify continued and expanded GenAI investment at board level.

The GCCs that present all three layers — with data for the first, targets for the second, and a credible roadmap to the third — consistently win faster budget approval and broader mandates than those presenting only operational efficiency data. Enorbe’s GCC advisory framework builds this measurement architecture alongside the GenAI deployment roadmap, ensuring the ROI story keeps pace with the GenAI delivery.

The Sequencing Risk: Why Most GCCs Get the Order Wrong

The most expensive mistake in GCC GenAI deployment is sequencing error: investing in long-term transformation infrastructure before proving quick wins, or pursuing only quick wins without building toward transformation. Both failure modes are common, and both are avoidable with deliberate planning.

GCCs that invest in transformation infrastructure prematurely — building large internal model development capabilities, custom LLM fine-tuning operations, or AI platform teams before they have solved the foundational data governance and talent challenges — consistently overspend and underdeliver. The infrastructure is there before the organisation is ready to use it.

Conversely, GCCs that deliver nothing but operational efficiency gains for two or three years find themselves in a credibility crisis when the parent company asks why the GCC is not contributing to product innovation or strategic differentiation. The quick wins have funded the budget but not built the capability. Correct sequencing — three to five quick wins in year one, capability-building in years two and three, transformation mandates by year four — produces the compound ROI curve that boards can see and fund.

Enorbe’s advisory team helps mid-market US and UK companies build GenAI ROI roadmaps that deliver measurable quick wins while building toward the long-term transformation that defines enterprise value. Book a strategy consultation at enorbe.com/contact-us or write to us at info@enorbe.com.